Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | SANA Sana Biotechnology, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $2.92 +0.2% | $16.31 +6.3% |
| StockIQ Score | 39F Weak Risk: High | 42D Weak Risk: Medium |
| Technical | 13F | 36F |
| Fundamental | 46D+ | 35F |
| Growth | 65B- | 50C- |
| Fair Value | 38F | 38F |
| News | 50C- | 50C- |
| Quality | — | 50C- |
| Risk | 40D | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
SANA shows stronger growth potential with a growth score of 65 versus AAPG’s 50, making it the better pick in that category. However, AAPG has a slightly higher investor score of 42 compared to SANA’s 39. Both stocks share the same weak rating and valuation score of 38, indicating similar risk levels in that area.
